Subscribe To
3 artificial intelligence (ai) stocks that could soar more than nvidia, according to wall street
SoundHound AI continues to score wins in the auto and restaurant industries with its voice AI technology. Schr...
September 25, 2023, 5:50 am
Is congestive heart failure reversible?
Congestive heart failure (CHF) is a condition in which your heart is no longer able to pump enough blood to consistently meet your body’s needs. It�...
September 24, 2023, 11:14 am
Aldeyra:upcoming pdufa, strong nda, long pipeline, decent cash
Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their ...
September 22, 2023, 7:44 pm
‘silver dollar road’ review: raoul peck’s intimate chronicle of a black family’s messy legal battle
The director of ‘I Am Not Your Negro’ and ‘Exterminate the Brutes’ offers a portrait of the Reels, a Black family trying to save their land fr...
September 22, 2023, 3:14 pm
‘silver dollar road’ review: raoul peck’s intimate chronicle of a black family’s messy legal battle
Later, through interviews with family members from Gertrude’s daughter Mamie Ellison to Melvin and Licurtis, a portrait of Silver Dollar Road’s co...
September 22, 2023, 3:14 pm
Zyversa therapeutics announces research published in the journal of clinical investigation reinforcing ic 100’s rationale for inhibiting asc specks to attenuate spread of inflammation into surrounding
Patients with chronic kidney disease (“CKD”) exhibit chro...
September 22, 2023, 10:35 am
Eli lilly, boehringer ingelheim's jardiance gets fda approval for chronic kidney disease
Eli Lilly & Co. LLY, -3.42% and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their blockbuster drug Jardia...
September 22, 2023, 8:49 am
Hepion pharmaceuticals to participate in 2023 cantor global healthcare conference
EDISON, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Art...
September 21, 2023, 4:05 pm
The good and bad: allison transmission & schrodinger inc.
See two of the featured stocks from this month's model portfolios....
September 21, 2023, 2:32 pm
Jasper therapeutics to present new positive data on briquilimab conditioning in patients with fanconi anemia at the 2023 fanconi anemia research fund scientific symposium
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
September 21, 2023, 8:00 am
Iv bags market predicted to reach usd 1.5 billion by 2032, expanding at a cagr of 5.8%: tmr report
The rising incidence of chronic ailments is the main driver for the IV bags market. Increases technolog...
September 20, 2023, 9:24 am
Syf vs. bx: which stock is the better value option?
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Synchrony (S...
September 19, 2023, 12:47 pm
Orchard's (ortx) rare neuro drug gets fda priority tag, stock up
Orchard's (ORTX) regulatory filing for OTL-200, in the treatment of pediatric patients suffering from metachro...
September 19, 2023, 11:18 am
Boston scientific to acquire relievant medsystems for $850 million upfront, plus milestone payments
Boston Scientific Corp. BSX, +0.19% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech compa...
September 19, 2023, 7:24 am
Here's why investors are retaining synchrony (syf) stock now
Synchrony's (SYF) Health & Wellness platform is expected to continue its growth track, thanks to a soli...
September 18, 2023, 2:18 pm
Verizon executive testifies google search always pre-installed on mobile phones
The U.S. Justice Department on Monday questioned a Verizon executive about the company's decision to always pre-install Google's ...
September 18, 2023, 12:15 pm
Orchard therapeutics: a reassessment
Orchard Therapeutics plc is a London-based biotech company focused on developing gene therapies for rare diseases. The company's lead therapy, OTL-200...
September 18, 2023, 9:20 am
Cymabay therapeutics to present at the cantor global healthcare conference
NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therap...
September 15, 2023, 8:00 am
Berry global: changes in capital allocation gives hope to shareholders
Berry Global operates in the stable and countercyclical plastic packaging sector. The company has been trading at a ...
September 15, 2023, 7:41 am
Cymabay announces closing of upsized $258.7 million public offering of common stock and pre-funded warrants, including full exercise of underwriters’ option to purchase additional shares
NEWARK, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on d...
September 14, 2023, 8:57 pm